Drug Testing Standards Clause Samples
The Drug Testing Standards clause establishes the requirements and procedures for conducting drug tests within an organization or under a contract. It typically outlines which substances are prohibited, the frequency and types of testing (such as random, pre-employment, or post-incident), and the protocols for handling positive results. This clause ensures a safe and compliant work environment by deterring substance abuse and providing clear guidelines for addressing violations.
Drug Testing Standards. A. Screening Test Standards: The following initial immunoassay test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs: Cocaine metabolites 300 ng/ml Opiate metabolites 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1000 ng/ml B Confirmatory Test Standards: All specimens identified as positive on the initial screening tests shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be by quantitative analysis. Concentrations which exceed the linear region of the standard curve shall be documented. Marijuana metabolites1 15 ng/ml Cocaine metabolites2 150 ng/ml Opiates: Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines: Amphetamine 500 ng/ml Methamphetamine 500 ng/ml 1Delta-9-tetrahydrocannabinol-9-carboxylic acid 2Benzoylecgonine
Drug Testing Standards. All testing will be conducted by an Agency for Health Care Administration approved laboratory; positive and negative test results will be reviewed by a certified Medical Review Officer to assure accuracy. All testing, specimen collection, security measures, monthly reports, storage, handling, chain of custody procedures, and quality control procedures will be performed in accordance with appropriate State and Federal rules and regulations. · The Agency for Health Care Administration may adopt additional rules to support this law and Part II of Chapter 408, using criteria established by the US Department of Health & Human Services as guidelines for laboratories: standards for licensing; technical assistance; appropriate specimens; methods of analysis; minimum cut-off detection levels; chain of custody procedures; and a list of common medications by brand or common, brand, and chemical name.
Drug Testing Standards. A. Initial Scre e ning Test Standards The initial test cut-off levels are de fine d as at or above : Initial Test Level ▇. Confirmatory Test Standards Drugs Confirmatory Test Le vel
Drug Testing Standards. A. Screening Test Standards
▇. Confirmatory Test Standards
Drug Testing Standards.
A. Screening Test Standards: The following initial immunoassay test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs: Marijuana Metabolites 100 ng/ml Cocaine Metabolites 300 ng/ml Opiate Metabolites 300 rig/m1 Phencyclidine 25 ng/ml Amphetamines 1000 ng/▇▇
▇. Confirmatory Test Standards: All specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below. All confirmations shall be quantitative analysis. Concentrations which exceed the linear region of the standard curve shall be documented. Marijuana Metabolites' 15 ng/ml Cocaine Metabolites2 150 ng/ml Opiates: Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines: Amphetamine 500 ng/ml Methamphetamine 500 ng/ml
Drug Testing Standards. Deleted: Marijuana
Drug Testing Standards. All specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques. All confirmations shall be by quantitative analysis.